David Winsemius MD, MPH, DBIM joined Hooper Holmes’ Heritage Labs as Vice President, Medical Director in May 2008. Dr. Winsemius has deep experience as medical director for both direct and reinsurance companies, most recently serving as Vice President and Medical Director for ING, concentrating on brokerage underwriting and mortality analysis. Dr Winsemius received his MD from the University of California, Davis, School of Medicine and his Masters of Public Health from the University of Washington. He holds a number of professional certifications, including Board Certification in Insurance Medicine, Board Certification in Family Practice, and the Certificate of Added Qualifications in Geriatrics. He currently serves as the Chair of the Mortality and Morbidity Committee for the American Association for Insurance Medicine, and is the Chair of the Morbidity-Mortality Liaison Committee, a joint research project of SOA, AAIM and AHOU. His special interest is in applying modern bio-statistical methods to practical insurance problems.Doug Ingle, FALU, FLMI, is Vice President of Underwriting Research for Hannover Life Re. He has over 37 years of underwriting experience split between direct writers and reinsurers. He completed Beginning and Advanced Life Table Methodology which studies methods for translating clinical medical research into mortality risk, co-founded PRiMA a program used for Preferred Risk underwriting and pricing, written a text on Interpreting resting EKG’s for underwriters, authored 2 chapters of the ALU curriculum, current member of the ILEC (Individual Life Experience Committee) is former chair of both the MMLC (Morbidity Mortality Liaison Committee which conducts intercompany insured lives studies) and UESC (Underwriting Experience Studies Committee), has written for On The Risk, Journal of Insurance Medicine, Contingencies, Best Review, and spoken at many regional underwriting meetings as well numerous presentations at the national SOA (Society of Actuaries), AAIM (American Academy of Insurance Medicine), and AHOU (Association of Home Office Underwriters) meetings.
About Hooper HolmesHooper Holmes is a leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. With presence in hundreds of markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Hooper Holmes has four divisions. Portamedic provides a wide range of medical exam services nationwide. Heritage Labs tests millions of samples annually and helps life insurers improve underwriting performance by better applying the predictive powers of today’s tests. Hooper Holmes Health & Wellness provides a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. Hooper Holmes Services reduces the insurance sales cycle through integrated data collection, tele-interviewing and underwriting services. This press release contains “forward-looking” statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the Company’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our ability to successfully implement our business strategy; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenant in our credit facility; our expectations regarding our operating cash flows; and the rate of life insurance application activity. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s annual report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission on March 9, 2012. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.